Blackstone Group »

Nurix Therapeutics shares owned by Blackstone Group

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Blackstone Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $280k 27k 10.32
2023-09-30 $213k 27k 7.86
2023-06-30 $271k 27k 9.99
2023-03-31 $241k 27k 8.88
2022-12-31 $298k 27k 10.98
2022-09-30 $353k 27k 13.02
2022-06-30 $214k 17k 12.69
2022-03-31 $236k 17k 14.00
2021-12-31 $411k 14k 28.97
2021-09-30 $425k 14k 29.95